Differentiation effects by the combination of spheroid formation and sodium butyrate treatment in human hepatoblastoma cell line (Hep G2): A possible cell source for hybrid artificial liver

Cell Transplantation

Volumn 14, Issue 10, 2005, Pages 819-827

  Fukuda, J ^a   Okamura, K ^a   Ishihara, K ^a   Mizumoto, H ^a   Nakazawa, K ^b   Ijima, H ^a   Kajiwara, T ^a   Funatsu, Kanimori ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF KITAKYUSHU   (Japan)

^c NONE   (Japan)

Author keywords

Hep G2; Hybrid artificial liver; Polyurethane foam; Sodium butyrate; Spheroid

Indexed keywords

ALBUMIN; AMMONIA; BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; ORNITHINE CARBAMOYLTRANSFERASE; POLYURETHAN FOAM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL LIVER; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; ENZYME ACTIVATION; FEASIBILITY STUDY; FEMALE; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HYBRID ARTIFICIAL LIVER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SPHEROID CELL; SWINE; TISSUE REGENERATION; UREA CYCLE;

ALBUMINS; AMMONIA; ANIMALS; BUTYRATES; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; FIBRINOGEN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOBLASTOMA; HEPATOCYTES; HISTONE DEACETYLASES; HUMANS; LACTIC ACID; LIVER NEOPLASMS; LIVER, ARTIFICIAL; ORNITHINE CARBAMOYLTRANSFERASE; POLYURETHANES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 31444440090     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000005783982503     Document Type: Article

References (40)

1. Candido, E. P.; Reeves, R.; Davie, J. R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14:105-113; 1978.
2. Chua, K. B.; Bellini, W. J.; Rota, P. A.; Harcourt, B. H.; Tamin, A.; Lam, S. K.; Ksiazek, T. G.; Rollin, P. E.; Zaki, S. R.; Shieh, W.; Goldsmith, C. S.; Gubler, D. J.; Roehrig, J. T.; Eaton, B.; Gould, A. R.; Olson, J.; Field, H.; Daniels, P.; Ling, A. E.; Peters, C. J.; Anderson, L. J.; Mahy, B. W. Nipah virus: A recently emergent deadly paramyxovirus. Science 288:1432-1435; 2000.
3. Clemmesen, J. O.; Larsen, F. S.; Kondrup, J.; Hansen, B. A.; Ott, P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29:648-653; 1999.
4. Cummings, J. H.; Pomare, E. W.; Branch, W. J.; Naylor, C. P.; Macfarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221-1227; 1987.
5. Curran, R. D.; Ferrari, F. K.; Kispert, P. H.; Stadler, J.; Stuehr, D. J.; Simmons, R. L.; Billiar, T. R. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5:2085-2092; 1991.
6. Davie, J. R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133:2485S-2493S; 2003.
7. Demetriou, A. A.; Brown, Jr., R. S.; Busuttil, R. W.; Fair, J.; McGuire, B. M.; Rosenthal, P.; Am Esch, II, J. S.; Lerut, J.; Nyberg, S. L.; Salizzoni, M.; Pagan, E. A.; de Hemptinne, B.; Broelsch, C. E.; Muraca, M.; Salmeron, J. M.; Rabkin, J. M.; Metselaar, H. J.; Pratt, D.; De La Mata, M.; McChesney, L. P.; Everson, G. T.; Lavin, P. T.; Stevens, A. C.; Pitkin, Z.; Solomon, B. A. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239:660-667; 2004.
8. Enosawa, S.; Suzuki, S.; Kakefuda, T.; Amemiya, H. Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell line. Cell Transplant. 5:S39-S40; 1996.
9. Fukuda, J.; Okamura, K.; Nakazawa, K.; Ijima, H.; Yamashita, Y.; Shimada, M.; Shirabe, K.; Tsujita, E.; Sugimachi, K.; Funatsu, K. Efficacy of a polyurethane foam/spheroid artificial liver by using human hepatoblastoma cell line (Hep G2). Cell Transplant. 12:51-58; 2003.
10. Fukuda, J.; Sakiyama, R.; Nakazawa, K.; Ijima, H.; Yamashita, Y.; Shimada, M.; Shirabe, K.; Tsujita, E.; Sugimachi, K.; Funatsu, K. Mass preparation of primary porcine hepatocytes and the design of a hybrid artificial liver module using spheroid culture for a clinical trial. Int. J. Artif. Organs 24:799-806; 2001.
11. Funatsu, K.; Nakazawa, K. Novel hybrid artificial liver using hepatocyte organoids. Int. J. Artif. Organs 25:77-82; 2002.
12. Gebhardt, R.; Mecke, D. Permissive effect of dexamethasone on glucagon induction of urea-cycle enzymes in perifused primary monolayer cultures of rat hepatocytes. Eur. J. Biochem. 97:29-35; 1979.
13. Gion, T.; Shimada, M.; Shirabe, K.; Nakazawa, K.; Ijima, H.; Matsushita, T.; Funatsu, K.; Sugimachi, K. Evaluation of a hybrid artificial liver using a polyurethane foam packed-bed culture system in dogs. J. Surg. Res. 82:131-136; 1999.
14. Guo, Z.; Yuan, C.; Wei-Lavery, T.; Fang, Y.; Garvin, R. A.; Nishida, H. I.; Nishida, T. Secretion of phospholipid transfer protein by human hepatoma cell line, Hep G2, is enhanced by sodium butyrate. J. Nutr. 129:1984-1991; 1999.
15. Hodin, R. A.; Meng, S.; Archer, S.; Tang, R. Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ. 7:647-653; 1996.
16. Hoshide, R.; Matsuura, T.; Sagara, Y.; Kubo, T.; Shimadzu, M.; Endo, F.; Matsuda, I. Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: A new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity. Am. J. Med. Genet. 64:459-464; 1996.
17. Ijima, H.; Matsushita, T.; Nakazawa, K.; Fujii, Y.; Funatsu, K. Hepatocyte spheroids in polyurethane foams: Functional analysis and application for a hybrid artificial liver. Tissue Eng. 4:213-226; 1998.
18. Kimura, T.; Chowdhury, S.; Tanaka, T.; Shimizu, A.; Iwase, K.; Oyadomari, S.; Gotoh, T.; Matsuzaki, H.; Mori, M.; Akira, S.; Takiguchi, M. CCAAT/enhancer-binding protein beta is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary-cultured hepatocytes. FEBS Lett. 494:105-111; 2001.
19. Nakazawa, K.; Ijima, H.; Fukuda, J.; Sakiyama, R.; Yamashita, Y.; Shimada, M.; Shirabe, K.; Tsujita, E.; Sugimachi, K.; Funatsu, K. Development of a hybrid artificial liver using polyurethane foam/hepatocyte spheroid culture in a preclinical pig experiment. Int. J. Artif. Organs 25:51-60; 2002.
20. Natsuka, S.; Akira, S.; Nishio, Y.; Hashimoto, S.; Sugita, T.; Isshiki, H.; Kishimoto, T. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79:460-466; 1992.
21. Nebes, V. L.; Morris, Jr., S. M. Regulation of messenger ribonucleic acid levels for five urea cycle enzymes in cultured rat hepatocytes. Requirements for cyclic adenosine monophosphate, glucocorticoids, and ongoing protein synthesis. Mol. Endocrinol. 2:444-451; 1988.
22. Nishiyori, A.; Tashiro, H.; Kimura, A.; Akagi, K.; Yamamura, K.; Mori, M.; Takiguchi, M. Determination of tissue specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors. Both HNF-4 and C/EBP beta are required for liver-specific activity of the ornithine transcarbamylase enhancer. J. Biol. Chem. 269:1323-1331; 1994.
23. Ohno, T.; Kimura, Y.; Sugimura, K.; Sagawa, A.; Jhodo, S.; Azuma, I. Elevated gene expression of argininosuccinate synthetase in peripheral lymphocytes from systemic lupus erythematosus (SLE) patients. Autoimmunity 13:127-132; 1992.
24. Paradis, K.; Langford, G.; Long, Z.; Heneine, W.; Sandstrom, P.; Switzer, W. M.; Chapman, L. E.; Lockey, C.; Onions, D.; The XEN 111 Study Group; Otto, E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 285:1236-1241; 1999.
25. Patience, C.; Takeuchi, Y.; Weiss, R. A. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3:282-286; 1997.
26. Piekarz, R.; Bates, S. A review of depsipeptide and other histone deacetylase inhibitors in clinical trials. Curr. Pharm. Des. 10:2289-2298; 2004.
27. Pitkin, Z.; Switzer, W.; Chapman, L. An interim analysis of PERV infectivity in 74 patients treated with a bioartificial liver in a prospective, randomized, multicenter controlled trial. Hepatology 34:249A; 2001.
28. Sauer, I. M.; Kardassis, D.; Zeillinger, K.; Pascher, A.; Gruenwald, A.; Pless, G.; Irgang, M.; Kraemer, M.; Puhl, G.; Frank, J.; Muller, A. R.; Steinmuller, T.; Denner, J.; Neuhaus, P.; Gerlach, J. C. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 10:460-469; 2003.
29. Suaud, L.; Joseph, B.; Formstecher, P.; Laine, B. mRNA expression of HNF-4 isoforms and of HNF-1alpha/HNF-1beta variants and differentiation of human cell lines that mimic highly specialized phenotypes of intestinal epithelium. Biochem. Biophys. Res. Commun. 235:820-825; 1997.
30. U.S. Public Health Service. U.S. Public Health Service guideline on infectious disease issues in xenotransplantation. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 50:1-46; 2001.
31. van de Kerkhove, M. P.; Hoekstra, R.; Chamuleau, R. A.; van Gulik, T. M. Clinical application of bioartificial liver support systems. Ann. Surg. 240:216-230; 2004.
32. van der Laan, L. J.; Lockey, C.; Griffeth, B. C.; Frasier, F. S.; Wilson, C. A.; Onions, D. E.; Hering, B. J.; Long, Z.; Otto, E.; Torbett, B. E.; Salomon, D. R. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 407:90-94; 2000.
33. van Wezel, A. L. Growth of cell-strains and primary cells on micro-carriers in homogeneous culture. Nature 216:64-65; 1967.
34. Wang, L.; Sun, J.; Li, L.; Mears, D.; Horvat, M.; Sheil, A. G. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transplant. 7:459-468; 1998.
35. Weiss, R. A. Retroviral zoonoses. Nat. Med. 4:391-392; 1998.
36. Yamamoto, H.; Fujimoto, J.; Okamoto, E.; Furuyama, J.; Tamaoki, T.; Hashimoto-Tamaoki, T. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. Int. J. Cancer 76:897-902; 1998.
37. Yamashita, Y.; Shimada, M.; Tsujita, E.; Tanaka, S.; Ijima, H.; Nakazawa, K.; Sakiyama, R.; Fukuda, J.; Ueda, T.; Funatsu, K.; Sugimachi, K. Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver. Cell Transplant. 10:717-722; 2001.
38. Yao, H.; Sadoshima, S.; Fujii, K.; Kusuda, K.; Ishitsuka, T.; Tamaki, K.; Fujishima, M. Cerebrospinal fluid lactate in patients with hepatic encephalopathy. Eur. Neurol. 27:182-187; 1987.
39. Yoon, J. H.; Lee, H. S.; Kim, T. H.; Woo, G. H.; Kim. C. Y. Augmentation of urea-synthetic capacity by inhibition of nitric oxide synthesis in butyrate-induced differentiated human hepatocytes. FEBS Lett. 474:175-178; 2000.
40. Yoon, J. H.; Lee, H. V.; Lee, J. S.; Park, J. B.; Kim, C. Y. Development of a non-transformed human liver cell line with differentiated-hepatocyte and urea-synthetic functions: Applicable for bioartificial liver. Int. J. Artif. Organs 22:769-777; 1999.